$10.60
2.03% yesterday
Nasdaq, Aug 11, 10:01 pm CET
ISIN
US18507C1036
Symbol
CLPT

ClearPoint Neuro Stock price

$10.60
-0.80 7.02% 1M
-7.16 40.30% 6M
-4.78 31.08% YTD
+0.82 8.38% 1Y
-5.37 33.63% 3Y
+6.60 165.00% 5Y
+9.87 1,352.05% 10Y
+9.85 1,313.33% 20Y
Nasdaq, Closing price Mon, Aug 11 2025
-0.22 2.03%
ISIN
US18507C1036
Symbol
CLPT

Key metrics

Basic
Market capitalization
$305.8m
Enterprise Value
$293.4m
Net debt
positive
Cash
$12.4m
Shares outstanding
28.0m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
9.5 | 7.9
EV/Sales
9.1 | 7.5
EV/FCF
negative
P/B
15.3
Financial Health
Equity Ratio
64.8%
Return on Equity
-74.5%
ROCE
-93.4%
ROIC
-146.1%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$32.2m | $38.9m
EBITDA
$-20.8m | $-13.2m
EBIT
$-21.7m | $-22.8m
Net Income
$-20.8m | $-22.0m
Free Cash Flow
$-11.7m
Growth (TTM | estimate)
Revenue
23.2% | 24.0%
EBITDA
-3.0% | 29.9%
EBIT
-3.4% | -15.4%
Net Income
-0.8% | -16.2%
Free Cash Flow
8.2%
Margin (TTM | estimate)
Gross
61.2%
EBITDA
-64.6% | -33.8%
EBIT
-67.3%
Net
-64.5% | -56.5%
Free Cash Flow
-36.4%
More
EPS
$-0.8
FCF per Share
$-0.4
Short interest
7.6%
Employees
115
Rev per Employee
$270.0k
Show more

Is ClearPoint Neuro a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,025 stocks worldwide.

ClearPoint Neuro Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a ClearPoint Neuro forecast:

7x Buy
88%
1x Hold
13%

Analyst Opinions

8 Analysts have issued a ClearPoint Neuro forecast:

Buy
88%
Hold
13%

Financial data from ClearPoint Neuro

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
32 32
23% 23%
100%
- Direct Costs 13 13
11% 11%
39%
20 20
32% 32%
61%
- Selling and Administrative Expenses 28 28
15% 15%
88%
- Research and Development Expense 13 13
16% 16%
41%
-21 -21
3% 3%
-65%
- Depreciation and Amortization 0.84 0.84
14% 14%
3%
EBIT (Operating Income) EBIT -22 -22
3% 3%
-67%
Net Profit -21 -21
1% 1%
-64%

In millions USD.

Don't miss a Thing! We will send you all news about ClearPoint Neuro directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

ClearPoint Neuro Stock News

Neutral
Accesswire
7 days ago
SOLANA BEACH, CALIFORNIA / ACCESS Newswire / August 4, 2025 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) ("Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced multiple key milestones demonstrating the progression of the Company's Biologics and Drug Delivery Portfolio including first commercial infusions in the United ...
Neutral
Accesswire
19 days ago
SOLANA BEACH, CALIFORNIA / ACCESS Newswire / July 23, 2025 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced that it will release financial results for its 2025 second quarter on Tuesday, August 12th, after the market close. Investors and analysts are invited to lis...
Neutral
24/7 Wall Street
about one month ago
Key Points in This Article: The Magnificent 7 transformed markets through AI and digital ecosystems, turning a once-pejorative label into a celebrated symbol of innovation and growth.
More ClearPoint Neuro News

Company Profile

Clearpoint Neuro, Inc. engages in the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain and heart. The firm conducts its procedures under direct, intra-procedural magnetic resonance imaging guidance. Its product platform consists of the ClearPoint system and ClearTrace system. The company was founded by Paul A. Bottomley on March 12, 1998 and is headquartered in Solana Beach, CA.

Head office United States
CEO Joseph Burnett
Employees 115
Founded 1998
Website www.clearpointneuro.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today